|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Jun―01 |
Neurotropic murine coronavirus mediated demyelination: Factors dampening pathogenesis |
Mihyun Hwang, Cornelia C. Bergmann |
2 |
[GO] |
2024―Apr―30 |
Causal association between multiple sclerosis and severe COVID-19: A bidirectional Mendelian randomization study |
Shuangjie Li, Dongren Sun, Rui Wang, Qin Du, Hongxi Chen, Ziyan Shi, Hongyu Zhou |
3 |
[GO] |
2024―Jan―08 |
SARS-CoV-2 induces inflammation and intracranial infection through the olfactory epithelium-olfactory bulb pathway in non-human primates |
Shino Shimizu, Misako Nakayama, Cong Thanh Nguyen, Hirohito Ishigaki, Yoshinori Kitagawa, Fumihiko Yasui, Yoshiki Yagi, Tomoe Kusayanagi, Michinori Kohara, Yasushi Itoh, Ichiro Tojima, Hideaki Kouzaki, Takeshi Shimizu |
4 |
[GO] |
2023―Nov―21 |
Hydroxyurea interaction with α7 nicotinic acetylcholine receptor can underlie its therapeutic efficacy upon COVID-19 |
Olena Lykhmus, Olena Kalashnyk, Raymond Sullivan, Maryna Skok |
5 |
[GO] |
2023―Nov―21 |
Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection |
Ying Chen, Wenbin Wan, Xiaoying Yao, Yangtai Guan |
6 |
[GO] |
2023―Sep―28 |
Humoral immune response to COVID-19 vaccine in patients with myasthenia gravis |
Sonja Holm-Yildiz, Tina Dysgaard, Thomas Krag, Britt Stævnsbo Pedersen, Sebastian Rask Hamm, Laura Pérez-Alós, Cecilie Bo Hansen, Mia Marie Pries-Heje, Line Dam Heftdal, Rasmus Bo Hasselbalch, Kamille Fogh, Johannes Roth Madsen, Ruth Frikke-Schmidt, Linda Maria Hilsted, Erik Sørensen, Sisse Rye Ostrowski, Henning Bundgaard, Peter Garred, Kasper Iversen, Susanne Dam Nielsen, John Vissing |
7 |
[GO] |
2023―Aug―29 |
SARS-CoV-2 mRNA vaccination induces an antigen-specific T cell response correlating with plasma interferon-gamma in B cell depleted patients |
Tyler L. Borko, Ryan Baxter, Berenice Cabrera-Martinez, Eagappanath Thiruppathi, Maite Sabalza, Iswariya Venkataraman, Sean Selva, Cody Rester, Stefan Sillau, Daniel M. Pastula, Jeffrey L. Bennett, Enrique Alvarez, Robert Gross, Anna Shah, Ryan Kammeyer, John R. Corboy, Ross M. Kedl, Elena W.Y. Hsieh, Amanda L. Piquet |
8 |
[GO] |
2023―Jun―17 |
Ablation of microglia following infection of the central nervous system with a neurotropic murine coronavirus infection leads to increased demyelination and impaired remyelination |
Yuting Cheng, Dominic Ibarra Javonillo, Collin Pachow, Vanessa M. Scarfone, Kellie Fernandez, Craig M. Walsh, Kim N. Green, Thomas E. Lane |
9 |
[GO] |
2022―Dec―23 |
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review |
Francesca Bosello, Damiano Marastoni, Francesca Benedetta Pizzini, Chiara Zaffalon, Andrea Zuliani, Giulia Turri, Sara Mariotto, Erika Bonacci, Emilio Pedrotti, Massimiliano Calabrese |
10 |
[GO] |
2022―Nov―28 |
Brain stem encephalitis is a rare complication of COVID-19 |
Marc C. Shamier, Yvette S. Crijnen, Susanne Bogers, Jeroen W. IJpelaar, Juna M. de Vries, Mathieu van der Jagt, Jochem K.H. Spoor, Jan H. von der Thüsen, Marco W.J. Schreurs, Corine H. GeurtsvanKessel, Maarten J. Titulaer |
11 |
[GO] |
2022―Oct―28 |
Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic review |
Ehab Harahsheh, Marcus Callister, Shemonti Hasan, David Gritsch, Cristina Valencia-Sanchez |
12 |
[GO] |
2022―Oct―17 |
Encephalitis, myocarditis, and thrombocytopenia after COVID-19 mRNA vaccination: Clinical and pathophysiological considerations |
Nicholas G. Kounis, Virginia Mplani, Periklis Dousdampanis, Panagiotis Plotas, Ioanna Koniari |
13 |
[GO] |
2022―Aug―02 |
Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review |
Parissa Feizi, Kanika Sharma, Shreya R. Pasham, Lalit Nirwan, Joe Joseph, Shruti Jaiswal, Shitiz Sriwastava |
14 |
[GO] |
2022―Jul―14 |
Myelin oligodendrocyte glycoprotein-IgG1 associated disorders (MOGAD) following SARS-CoV-2 infection: A case series |
Jeffrey Lambe, Marisa P. McGinley, Brandon P. Moss, Yang Mao-Draayer, Roman Kassa, John R. Ciotti, Sara Mariotto, Amy Kunchok |
15 |
[GO] |
2022―May―08 |
COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case report |
Md Asaduzzaman, Bidrum Purkayastha, M. M. Jahangir Alam, Shishir Ranjan Chakraborty, Soumitra Roy, Nasad Ahmed |
16 |
[GO] |
2022―Apr―22 |
Changes in ganglioside antibody positivity rates during the COVID-19 pandemic |
Michael K. Racke, Justin K. Niles, Raymond A. Lorenz, Harvey W. Kaufman |
17 |
[GO] |
2022―Mar―05 |
The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit |
Pablo Diaz, Marie Leveque, Geoffroy Hautecloque, François Sellal, Olivier Augereau, Livinia Lita, Estelle Biegle, Lounis Belilita, Charles Boutera, Pierre Rerat, Antonio Alvarez Gonzalez, Martin Martinot, Victor Gerber |
18 |
[GO] |
2021―Dec―13 |
Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab |
Ivan Adamec, Dunja Rogić, Monika-Gabriele Penz, Carola Braun, Mario Habek |
19 |
[GO] |
2021―Dec―09 |
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure |
Karlo Toljan, Moein Amin, Amy Kunchok, Daniel Ontaneda |
20 |
[GO] |
2021―Dec―08 |
Stellate ganglion block reduces symptoms of long COVID: A case series |
Luke D. Liu, Deborah L. Duricka |
21 |
[GO] |
2021―Nov―18 |
Comments on “Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine” by , J Neuroimmunol |
Céline Caravagna |
22 |
[GO] |
2021―Nov―09 |
A systematic review of cases of CNS demyelination following COVID-19 vaccination |
Ismail Ibrahim Ismail, Sara Salama |
23 |
[GO] |
2021―Oct―21 |
Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine |
Juichi Fujimori, Kouichi Miyazawa, Ichiro Nakashima |
24 |
[GO] |
2021―Oct―06 |
Longitudinally extensive transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies following SARS-CoV-2 infection |
Mariana Dias da Costa, Miguel Leal Rato, Diana Cruz, Anabela Valadas, Ana Patrícia Antunes, Luísa Albuquerque |
25 |
[GO] |
2021―Sep―29 |
The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases |
Viviana Falcón Cama, Javier Marín-Prida, Nelson Acosta-Rivero, Emilio F. Acosta, Leonardo Oramas Díaz, Ana V. Casadesús, Briandy Fernández-Marrero, Nathalie Gilva-Rodríguez, Daina Cremata-García, Majel Cervantes-Llanos, Beatriz Piniella-Matamoros, Daisy Sánchez, Leticia del Rosario-Cruz, Israel Borrajero, Angelina Díaz, Yorexis González, Eduardo Pentón-Arias, Teresita Montero-González, Gerardo Guillen-Nieto, Giselle Pentón-Rol |
26 |
[GO] |
2021―Sep―17 |
AstraZeneca COVID-19 vaccine and Guillain-Barre’ Syndrome in Tasmania: A causal link? |
Wai M. Oo, Pradeep Giri, Aaron De Souza |
27 |
[GO] |
2021―Aug―28 |
Longitudinally extensive transverse myelitis as a sign of multisystem inflammatory syndrome following COVID-19 infection: A pediatric case report |
Zahra Pourmoghaddas, Atefeh Sadeghizadeh, Seyedeh Zahra Tara, Alireza Zandifar, Hamid Rahimi, Rana Saleh, Mohammadreza Ghazavi, Omid Yaghini, Neda Hosseini, Niloofar Javadi, Mohammad Saadatnia, Arastoo Vossough |
28 |
[GO] |
2021―Aug―28 |
SARS-CoV-2 vaccinations may not only be complicated by GBS but also by distal small fibre neuropathy |
Josef Finsterer |
29 |
[GO] |
2021―Aug―16 |
Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study |
Mario Habek, Gregor Jakob Brecl, Vanja Bašić Kes, Dunja Rogić, Barbara Barun, Tereza Gabelić, Andreja Emeršič, Alenka Horvat Ledinek, Nevena Grbić, Ivana Lapić, Dragan Šegulja, Koraljka Đurić, Ivan Adamec, Magdalena Krbot Skorić |
30 |
[GO] |
2021―Aug―08 |
COVID-19 in Cladribine-treated patient with multiple sclerosis |
Nitsan Haham, Adi Vaknin-Dembinsky |
31 |
[GO] |
2021―Aug―08 |
Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature |
Young Gi Min, Woohee Ju, Ye-Eun Ha, Jae-Jun Ban, Seolah Lee, Jung-Joon Sung, Je-Young Shin |
32 |
[GO] |
2021―Jul―31 |
Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association? |
Elisa Vegezzi, Sabrina Ravaglia, Gabriele Buongarzone, Paola Bini, Luca Diamanti, Matteo Gastaldi, Paolo Prunetti, Elisa Rognone, Enrico Marchioni |
33 |
[GO] |
2021―Jul―27 |
Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases |
Laura Zelada-Ríos, Kevin Pacheco-Barrios, Milagros Galecio-Castillo, Cesar Yamunaqué, Kelvin Álvarez, Ricardo Otiniano-Sifuentes |
34 |
[GO] |
2021―Jul―13 |
Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine |
Luca Baldelli, Giulia Amore, Angelica Montini, Ivan Panzera, Simone Rossi, Pietro Cortelli, Maria Guarino, Rita Rinaldi, Roberto D'Angelo |
35 |
[GO] |
2021―Jul―10 |
Commentary: The spectrum of neurological manifestations related to COVID-19 and vaccinations |
Rohini D. Samudralwar |
36 |
[GO] |
2021―Jul―10 |
Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms |
Anton Johansson, Mohamed S. Mohamed, Thiago C. Moulin, Helgi B. Schiöth |
37 |
[GO] |
2021―Jun―30 |
Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis |
Ritwik Ghosh, Souvik Dubey, Arpan Mandal, Biman Kanti Ray, Julian Benito-León |
38 |
[GO] |
2021―Jun―24 |
A case of longitudinally extensive transverse myelitis following vaccination against Covid-19 |
Claudia Pagenkopf, Martin Südmeyer |
39 |
[GO] |
2021―Jun―12 |
Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis |
Jibrin Danladi, Hemmen Sabir |
40 |
[GO] |
2021―Jun―07 |
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement |
Saúl Reyes, Anthony L. Cunningham, Tomas Kalincik, Eva Kubala Havrdová, Noriko Isobe, Julia Pakpoor, Laura Airas, Reem F. Bunyan, Anneke van der Walt, Jiwon Oh, Joela Mathews, Farrah J. Mateen, Gavin Giovannoni |
41 |
[GO] |
2021―Jun―07 |
New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine |
Yasser Aladdin, Bader Shirah |
42 |
[GO] |
2021―Jun―05 |
Dimensions of SARS-CoV-2 associated Guillain-Barré syndrome |
J. Finsterer, R. Ghosh |
43 |
[GO] |
2021―May―29 |
Post-infectious rhombencephalitis after coronavirus-19 infection: A case report and literature review |
Valerie Jeanneret, Daniel Winkel, Aida Risman, Hang Shi, Grace Gombolay |
44 |
[GO] |
2021―May―13 |
Diagnosing SARS-CoV-2 associated Guillain-Barre syndrome requires cerebro-spinal-fluid studies |
Josef Finsterer, Fulvio A. Scorza, Carla A. Scorza, Ana C. Fiorini |
45 |
[GO] |
2021―May―04 |
Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients |
Hannah Kelly, Brent Sokola, Hesham Abboud |
46 |
[GO] |
2021―Apr―28 |
Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up |
Nowshin Papri, Shoma Hayat, Asif Mohammed, Md. Nure Alam Afsar, Imran Hasan, Ananna Rahman, Israt Jahan, Zhahirul Islam |
47 |
[GO] |
2021―Apr―18 |
Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review |
Abu Baker Sheikh, Prabal Kumar Chourasia, Nismat Javed, Mehul Kumar Chourasia, Sajid S. Suriya, Shubhra Upadhyay, Fatima Ijaz, Suman Pal, Narges Moghimi, Rahul Shekhar |
48 |
[GO] |
2021―Apr―16 |
Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities |
Homa Pourriyahi, Amene Saghazadeh, Nima Rezaei |
49 |
[GO] |
2021―Apr―01 |
Steroid-responsive, transverse myelitis is a known complication of COVID-19 |
J. Finsterer |
50 |
[GO] |
2021―Feb―21 |
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature |
Maria M. Escobar, Saurabh Kataria, Erum Khan, Roshan Subedi, Medha Tandon, Kirthika Peshwe, Joshua Kramer, Faraze Niaze, Shitiz Sriwastava |
51 |
[GO] |
2021―Feb―15 |
COVID-19, HHV6 and MOG antibody: A perfect storm |
Muruj Jumah, Farah Rahman, Mark Figgie, Ankita Prasad, Anthony Zampino, Ali Fadhil, Kaitlin Palmer, Robin Arthur Buerki, Steven Gunzler, Praveen Gundelly, Hesham Abboud |
52 |
[GO] |
2020―Nov―11 |
A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection |
Ritwik Ghosh, Kaustav De, Devlina Roy, Arpan Mandal, Subrata Biswas, Subhrajyoti Biswas, Swagatam Sengupta, Dinabandhu Naga, Mrinalkanti Ghosh, Julián Benito-León |
53 |
[GO] |
2020―Nov―07 |
COVID-19 associated with sensorimotor polyradiculoneuropathy and skin lesions: A case report |
Reza Boostani, Fariborz Reazai Talab, Naser Tayyebi Meibodi, Fariba Zemorshidi |
54 |
[GO] |
2020―Nov―07 |
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation |
Kiandokht Keyhanian, Raffaella Pizzolato Umeton, Babak Mohit, Vahid Davoudi, Fatemeh Hajighasemi, Mehdi Ghasemi |
55 |
[GO] |
2020―Sep―25 |
Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM) |
Omar Hussein, Ahmed Abd Elazim, Michel T. Torbey |
56 |
[GO] |
2020―Sep―24 |
COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment |
Lorenzo Muccioli, Umberto Pensato, Ilaria Cani, Luca Guerra, Federica Provini, Giorgio Bordin, Luca Albini Riccioli, Raffaele Lodi, Paolo Tinuper, Francesca Bisulli |
57 |
[GO] |
2020―Jul―15 |
The peripheral blood immune cell profile in a teriflunomide-treated multiple sclerosis patient with COVID-19 pneumonia |
Maria Rosa Ciardi, Maria Antonella Zingaropoli, Patrizia Pasculli, Valentina Perri, Matteo Tartaglia, Serena Valeri, Gianluca Russo, Antonella Conte, Claudio Maria Mastroianni |
58 |
[GO] |
2020―Jul―14 |
Hemorrhagic encephalopathy associated with COVID-19 |
Jonathan D. Krett, Gordon A.E. Jewett, Charissa Elton-Lacasse, Kevin Fonseca, Christopher Hahn, Selena Au, Marcus W. Koch |
59 |
[GO] |
2020―Jun―20 |
Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report |
Mohammad Amin Farzi, Hormoz Ayromlou, Naser Jahanbakhsh, Parisa Hadavi Bavil, Abdolali Janzadeh, Farid Karkon Shayan |
60 |
[GO] |
2020―May―31 |
Multiple sclerosis and COVID-19: A great opportunity for databases promoting research and collaboration |
Michael K. Racke, Scott D. Newsome |
61 |
[GO] |
2020―May―29 |
Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection |
Marco Chiarini, Simone Paghera, Daniele Moratto, Nicola De Rossi, Mauro Giacomelli, Raffaele Badolato, Ruggero Capra, Luisa Imberti |
62 |
[GO] |
2020―Mar―04 |
HLA associations in narcolepsy type 1 persist after the 2009 H1N1 pandemic |
Mink Schinkelshoek, Rolf Fronczek, Willem Verduijn, Geert Haasnoot, Sebastiaan Overeem, Claire Donjacour, Astrid van der Heide, Dave Roelen, Frans Claas, Gert Jan Lammers |